46
Participants
Start Date
October 31, 2007
Primary Completion Date
June 30, 2011
Study Completion Date
September 30, 2012
Clofarabine/Busulfan x 4
"Clofarabine IV (dose levels)~* 1st dose level: 20 mg/m2/day x 5 days~* 2nd dose level: 30 mg/m2/day x 5 days~* 3rd dose level: 40 mg/m2/day x 5 days~Busulfan IV 3.2 mg/kg daily x 4 days"
Peripheral blood stem cell transplant
Peripheral blood stem cell transplant, after pre-conditioning drug treatment
Total Lymphoid Irradiation
Total Lymphoid Irradiation (TLI) of 4 Gy, if cord blood transplant
University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program, Ann Arbor
Genzyme, a Sanofi Company
INDUSTRY
University of Michigan Rogel Cancer Center
OTHER